ADC Therapeutics
ADCT
ADCT
74 hedge funds and large institutions have $164M invested in ADC Therapeutics in 2024 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 13 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
11.83% more ownership
Funds ownership: 42.03% → 53.85% (+12%)
5% more capital invested
Capital invested by funds: $156M → $164M (+$7.97M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
74
Holding in Top 10
3
Calls
$1.14M
Puts
$201K
Top Buyers
| 1 | +$13.6M | |
| 2 | +$11.2M | |
| 3 | +$7.96M | |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$4.1M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$4.01M |
Top Sellers
| 1 | -$4.49M | |
| 2 | -$2.88M | |
| 3 | -$2.25M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$1.09M |
| 5 |
Millennium Management
New York
|
-$613K |